Authorities in the United States and Europe are facing a new technological challenge in the fight against opioids. Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, have emerged as a deadly threat, causing numerous deaths in both regions. These drugs, initially developed by CIBA Aktiengesellschaft in the 1950s, were originally intended as painkillers but failed to gain traction due to their addictive and harmful nature.
Despite their obscurity for decades, nitazenes have resurfaced in the illegal market, gaining popularity among drug manufacturers and dealers for their potency and similarity to well-known opioids like heroin. The allure of cutting other drugs to increase profits has made nitazenes a concerning addition to the illicit drug trade. The lack of awareness among users about the substances they are consuming has heightened the risk of overdoses and fatalities.
Law enforcement agencies began detecting nitazenes about six years ago, with notable seizures and deaths reported since. The technological complexity involved in identifying these synthetic drugs poses a significant challenge, as routine tests do not readily detect them. The resurgence of nitazenes underscores the evolving landscape of drug trafficking and the need for advanced technological solutions to combat the proliferation of dangerous substances.
Source: WIRED